Regeneron Says FDA Approves Pasatru (Garetosmab-Grts) For Adults With Fibrodysplasia Ossificans Progressiva - REGN News | RalliesRegeneron Says FDA Approves Pasatru (Garetosmab-Grts) For Adults With Fibrodysplasia Ossificans Progressiva
R
REGN• FDA approves Pasatru for adults with fibrodysplasia ossificans progressiva
- Regeneron Pharmaceuticals, Inc. said the FDA approves Pasatru (garetosmab-grts) for adults with fibrodysplasia ossificans progressiva.
- Pasatru is under review by the European Medicines Agency; global submissions are planned.
OLP
•
